title: Response to Tung et al.
authors.forename: María
authors.initials: M
authors.lastname: Chaparro
authors.forename: Javier P
authors.initials: JP
authors.lastname: Gisbert
mesh_terms: D005260:Female; D006509:Hepatitis B / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000276:immunology*; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D017325:Hepatitis B Vaccines; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha